T. Horňák

发表

Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice

H. Klamová, Tereza Nečasová, J. Mayer, 2020, Leukemia & lymphoma.

Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients – results from real-life prospective study

E. Faber, P. Žák, J. Mayer, 2020, Leukemia & lymphoma.

Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF

P. Jindra, A. Folta, T. Papajík, 2024, Leukemia.